{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:01:29Z","timestamp":1791403289115,"version":"4.3.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T00:00:00Z","timestamp":1729036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T00:00:00Z","timestamp":1729036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s13555-024-01280-3","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T16:02:56Z","timestamp":1729094576000},"page":"3243-3258","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Alopecia Areata Treatment Patterns and Satisfaction: Results of a Real-World Cross-Sectional Survey in Europe"],"prefix":"10.1007","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2171-8228","authenticated-orcid":false,"given":"Peter","family":"Anderson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7015-1021","authenticated-orcid":false,"given":"James","family":"Piercy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4297-6290","authenticated-orcid":false,"given":"Jenny","family":"Austin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0380-0372","authenticated-orcid":false,"given":"Simran","family":"Marwaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7201-3324","authenticated-orcid":false,"given":"Kent A.","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6111-8008","authenticated-orcid":false,"given":"Ernest H.","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2392-8111","authenticated-orcid":false,"given":"Samantha K.","family":"Kurosky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2773-7494","authenticated-orcid":false,"given":"Sergio","family":"Va\u00f1\u00f3-Galv\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,16]]},"reference":[{"issue":"1","key":"1280_CR1","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/DAD.0b013e318185a66e","volume":"31","author":"ED Cetin","year":"2009","unstructured":"Cetin ED, Savk E, Uslu M, Eskin M, Karul A. Investigation of the inflammatory mechanisms in alopecia areata. Am J Dermatopathol. 2009;31(1):53\u201360.","journal-title":"Am J Dermatopathol"},{"issue":"1","key":"1280_CR2","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1038\/jidsymp.2013.4","volume":"16","author":"MK Hordinsky","year":"2013","unstructured":"Hordinsky MK. Overview of alopecia areata. J Investig Dermatol Symp Proc. 2013;16(1):S13\u20135.","journal-title":"J Investig Dermatol Symp Proc"},{"issue":"2","key":"1280_CR3","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.autrev.2014.10.014","volume":"14","author":"N Islam","year":"2015","unstructured":"Islam N, Leung PSC, Huntley AC, Gershwin ME. The autoimmune basis of alopecia areata: a comprehensive review. Autoimmun Rev. 2015;14(2):81\u20139.","journal-title":"Autoimmun Rev"},{"issue":"1","key":"1280_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaad.2017.04.1141","volume":"78","author":"LC Strazzulla","year":"2018","unstructured":"Strazzulla LC, Wang EHC, Avila L, et al. Alopecia areata: Disease characteristics, clinical evaluation, and new perspectives on pathogenesis. J Am Acad Dermatol. 2018;78(1):1\u201312.","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"1280_CR5","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1007\/s13555-023-00941-z","volume":"13","author":"N Mesinkovska","year":"2023","unstructured":"Mesinkovska N, Craiglow B, Ball SG, et al. The Invisible Impact of a Visible Disease: Psychosocial Impact of Alopecia Areata. Dermatol Ther (Heidelb). 2023;13(7):1503\u201315.","journal-title":"Dermatol Ther (Heidelb)."},{"issue":"1","key":"1280_CR6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2174\/1573396316666200430084825","volume":"17","author":"R Afford","year":"2021","unstructured":"Afford R, Leung AKC, Lam JM. Pediatric Alopecia Areata. Curr Pediatr Rev. 2021;17(1):45\u201354.","journal-title":"Curr Pediatr Rev"},{"issue":"2","key":"1280_CR7","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/ajd.12941","volume":"60","author":"WC Cranwell","year":"2019","unstructured":"Cranwell WC, Lai VW, Photiou L, et al. Treatment of alopecia areata: An Australian expert consensus statement. Australas J Dermatol. 2019;60(2):163\u201370.","journal-title":"Australas J Dermatol"},{"issue":"6","key":"1280_CR8","doi-asserted-by":"publisher","first-page":"609","DOI":"10.23736\/S0392-0488.19.06458-7","volume":"154","author":"A Rossi","year":"2019","unstructured":"Rossi A, Muscianese M, Piraccini BM, et al. Italian Guidelines in diagnosis and treatment of alopecia areata. G Ital Dermatol Venereol. 2019;154(6):609\u201323.","journal-title":"G Ital Dermatol Venereol"},{"issue":"1","key":"1280_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jaad.2017.04.1142","volume":"78","author":"LC Strazzulla","year":"2018","unstructured":"Strazzulla LC, Wang EHC, Avila L, et al. Alopecia areata: an appraisal of new treatment approaches and overview of current therapies. J Am Acad Dermatol. 2018;78(1):15\u201324.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"1280_CR10","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1159\/000501940","volume":"5","author":"AK Gupta","year":"2019","unstructured":"Gupta AK, Carviel JL, Foley KA, et al. Monotherapy for alopecia areata: a systematic review and network meta-analysis. Skin Appendage Disord. 2019;5(6):331\u20137.","journal-title":"Skin Appendage Disord."},{"issue":"2s","key":"1280_CR11","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1016\/j.jaad.2023.05.049","volume":"89","author":"BA King","year":"2023","unstructured":"King BA, Craiglow BG. Janus kinase inhibitors for alopecia areata. J Am Acad Dermatol. 2023;89(2s):S29-s32.","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"1280_CR12","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1185\/03007990802457040","volume":"24","author":"P Anderson","year":"2008","unstructured":"Anderson P, Benford M, Harris N, Karavali M, Piercy J. Real-world physician and patient behaviour across countries: disease-Specific Programmes\u2014a means to understand. Curr Med Res Opin. 2008;24(11):3063\u201372.","journal-title":"Curr Med Res Opin"},{"issue":"8","key":"1280_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-010352","volume":"6","author":"SM Babineaux","year":"2016","unstructured":"Babineaux SM, Curtis B, Holbrook T, Milligan G, Piercy J. Evidence for validity of a national physician and patient-reported, cross-sectional survey in China and UK: the Disease Specific Programme. BMJ Open. 2016;6(8): e010352.","journal-title":"BMJ Open"},{"key":"1280_CR14","doi-asserted-by":"publisher","first-page":"371","DOI":"10.2147\/DMSO.S120101","volume":"9","author":"V Higgins","year":"2016","unstructured":"Higgins V, Piercy J, Roughley A, et al. Trends in medication use in patients with type 2 diabetes mellitus: a long-term view of real-world treatment between 2000 and 2015. Diabetes Metab Syndr Obes. 2016;9:371\u201380.","journal-title":"Diabetes Metab Syndr Obes."},{"issue":"12","key":"1280_CR15","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1080\/03007995.2023.2279679","volume":"39","author":"P Anderson","year":"2023","unstructured":"Anderson P, Higgins V, Courcy J, et al. Real-world evidence generation from patients, their caregivers and physicians supporting clinical, regulatory and guideline decisions: an update on Disease Specific Programmes. Curr Med Res Opin. 2023;39(12):1707\u201315.","journal-title":"Curr Med Res Opin"},{"key":"1280_CR16","unstructured":"ephmra.org. Code of Conduct and Adverse Event Reporting Guidelines. 2022."},{"key":"1280_CR17","unstructured":"healthit.gov. Index for Excerpts from the American Recovery and Reinvestment Act of 2009 (ARRA) 2009"},{"key":"1280_CR18","unstructured":"StataCorp. Stata Statistical Software: Release 17. College Station, TX: StataCorp LLC; 2021."},{"key":"1280_CR19","first-page":"397","volume":"8","author":"AC Villasante Fricke","year":"2015","unstructured":"Villasante Fricke AC, Miteva M. Epidemiology and burden of alopecia areata: a systematic review. Clin Cosmet Investig Dermatol. 2015;8:397\u2013403.","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"2","key":"1280_CR20","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.jaad.2018.07.013","volume":"80","author":"S Lee","year":"2019","unstructured":"Lee S, Lee H, Lee CH, Lee WS. Comorbidities in alopecia areata: a systematic review and meta-analysis. J Am Acad Dermatol. 2019;80(2):466-77.e16.","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"1280_CR21","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1001\/jamadermatol.2013.3049","volume":"149","author":"KP Huang","year":"2013","unstructured":"Huang KP, Mullangi S, Guo Y, Qureshi AA. Autoimmune, atopic, and mental health comorbid conditions associated with alopecia areata in the United States. JAMA Dermatol. 2013;149(7):789\u201394.","journal-title":"JAMA Dermatol"},{"issue":"4","key":"1280_CR22","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.jaip.2020.01.052","volume":"8","author":"K Kridin","year":"2020","unstructured":"Kridin K, Renert-Yuval Y, Guttman-Yassky E, Cohen AD. Alopecia areata is associated with atopic diathesis: results from a population-based study of 51,561 patients. J Allergy Clin Immunol Pract. 2020;8(4):1323-8.e1.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"1280_CR23","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.jaad.2019.11.064","volume":"82","author":"YX Dai","year":"2020","unstructured":"Dai YX, Tai YH, Chen CC, Chang YT, Chen TJ, Chen MH. Bidirectional association between alopecia areata and major depressive disorder among probands and unaffected siblings: a nationwide population-based study. J Am Acad Dermatol. 2020;82(5):1131\u20137.","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"1280_CR24","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1111\/cea.13729","volume":"50","author":"YH Wei","year":"2020","unstructured":"Wei YH, Tai YH, Dai YX, Chang YT, Chen TJ, Chen MH. Bidirectional association between alopecia areata and atopic dermatitis: A population-based cohort study in Taiwan. Clin Exp Allergy. 2020;50(12):1406\u201314.","journal-title":"Clin Exp Allergy"},{"issue":"4","key":"1280_CR25","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1001\/jamadermatol.2018.4398","volume":"155","author":"IA Vallerand","year":"2019","unstructured":"Vallerand IA, Lewinson RT, Parsons LM, et al. Assessment of a bidirectional association between major depressive disorder and alopecia areata. JAMA Dermatol. 2019;155(4):475\u20139.","journal-title":"JAMA Dermatol"},{"key":"1280_CR26","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2147\/CCID.S245649","volume":"13","author":"M Benigno","year":"2020","unstructured":"Benigno M, Anastassopoulos K, Mostaghimi A, et al. A large cross-sectional survey study of the prevalence of alopecia areata in the United States. Clin Cosmet Investig Dermatol. 2020;13:259\u201366.","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"3","key":"1280_CR27","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.jaad.2006.05.008","volume":"55","author":"A Tosti","year":"2006","unstructured":"Tosti A, Bellavista S, Iorizzo M. Alopecia areata: a long term follow-up study of 191 patients. J Am Acad Dermatol. 2006;55(3):438\u201341.","journal-title":"J Am Acad Dermatol"},{"key":"1280_CR28","doi-asserted-by":"publisher","first-page":"17011","DOI":"10.1038\/nrdp.2017.11","volume":"3","author":"CH Pratt","year":"2017","unstructured":"Pratt CH, King LE Jr, Messenger AG, Christiano AM, Sundberg JP. Alopecia areata Nat Rev Dis Primers. 2017;3:17011.","journal-title":"Alopecia areata Nat Rev Dis Primers."},{"issue":"9","key":"1280_CR29","first-page":"751","volume":"61","author":"F Spano","year":"2015","unstructured":"Spano F, Donovan JC. Alopecia areata: Part 1: pathogenesis, diagnosis, and prognosis. Can Fam Physician. 2015;61(9):751\u20135.","journal-title":"Can Fam Physician"},{"key":"1280_CR30","unstructured":"Spano F, Donovan JC. Alopecia areata. Part 1: pathogenesis, diagnosis, and prognosis. 2015;61(9):751\u20135."},{"issue":"1","key":"1280_CR31","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jaad.2020.03.004","volume":"83","author":"N Meah","year":"2020","unstructured":"Meah N, Wall D, York K, et al. The Alopecia Areata Consensus of Experts (ACE) study: Results of an international expert opinion on treatments for alopecia areata. J Am Acad Dermatol. 2020;83(1):123\u201330.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"1280_CR32","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1111\/j.1365-2133.2012.10955.x","volume":"166","author":"AG Messenger","year":"2012","unstructured":"Messenger AG, McKillop J, Farrant P, McDonagh AJ, Sladden M. British Association of Dermatologists\u2019 guidelines for the management of alopecia areata 2012. Br J Dermatol. 2012;166(5):916\u201326.","journal-title":"Br J Dermatol"},{"issue":"4","key":"1280_CR33","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s13555-022-00702-4","volume":"12","author":"HL Gelhorn","year":"2022","unstructured":"Gelhorn HL, Cutts K, Edson-Heredia E, et al. The relationship between patient-reported severity of hair loss and health-related quality of life and treatment patterns among patients with alopecia areata. Dermatol Ther (Heidelb). 2022;12(4):989\u201397.","journal-title":"Dermatol Ther (Heidelb)."},{"issue":"9","key":"1280_CR34","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.7326\/M22-1460","volume":"175","author":"LM DeTora","year":"2022","unstructured":"DeTora LM, Toroser D, Sykes A, et al. Good publication practice (GPP) guidelines for company-sponsored biomedical research: 2022 update. Ann Intern Med. 2022;175(9):1298\u2013304.","journal-title":"Ann Intern Med"}],"updated-by":[{"DOI":"10.1007\/s13555-024-01307-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000}}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-024-01280-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-024-01280-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-024-01280-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T04:48:43Z","timestamp":1732855723000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-024-01280-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,16]]},"references-count":34,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1280"],"URL":"https:\/\/doi.org\/10.1007\/s13555-024-01280-3","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s13555-024-01307-9","asserted-by":"object"}]},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,16]]},"assertion":[{"value":"13 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s13555-024-01307-9","URL":"https:\/\/doi.org\/10.1007\/s13555-024-01307-9","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Peter Anderson, James Piercy, Simran Marwaha, and Jenny Austin are employees of Adelphi Real World. Kent A. Hanson serves as a consultant to Pfizer and receives compensation for these services. Ernest H. Law, Gregor Schaefer, and Samantha K. Kurosky are employees of and hold stock in Pfizer. Sergio Va\u00f1\u00f3-Galv\u00e1n has received research funding from Pfizer and Eli Lilly and honoraria for work as a consultant and\/or speaker from Pfizer and Eli Lilly.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Patients provided informed consent for the use of their anonymized and aggregated data for research and publication in scientific journals. Data were collected in such a way that patients and dermatologists could not be identified directly; all data were aggregated and de-identified before receipt. Data collection was undertaken in line with European Pharmaceutical Marketing Research Association guidelines [], and did not require Institutional Review Board\/Independent Ethics Committee approval. The AA Disease Specific Programme was issued an ethics exemption by the Western IRB (study protocol number: AG-8446). The DSP was performed in full accordance with relevant legislation at the time of data collection, including the Health Information Technology for Economic and Clinical Health Act legislation []. No new surveys were sent out to patients as part of this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}